Descriptions of acute transfusion reactions in the teaching hospitals of Kermanshah University of Medical Sciences, Iran

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 7, Issue 2, 2013, Pages 11-16

  Payandeh, Mehrdad ^a   Zare, Mohammad Erfan ^a,b   Kansestani, Atefeh Nasir ^b   Pakdel, Shirin Falah ^a   Jahanpour, Firuzeh ^a   Yousefi, Hoshang ^c   Soleimanian, Farzaneh ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Acute transfusion reactions; Febrile non hemolytic transfusion reaction

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ALLERGIC REACTION; APPLICATION SITE PAIN; ARTICLE; BLOOD COMPONENT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL FEATURE; FEBRILE NONHEMOLYTIC TRANSFUSION REACTION; FEMALE; HUMAN; HYPOTENSION; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; RASH; SKIN PRURITUS; TEACHING HOSPITAL; URTICARIA;

EID: 84876801242     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Serious hazards of transfusion annual report 1998-1999 (internet). Manchester (UK): SHOT Office; accessed 2003 Dec 12. Available from: http://www.shot.demon.co.uk
2. Serious hazards of transfusion annual report 1999-2000 (internet). Manchester (UK): SHOT Office; accessed 2003 Dec 12. Available from: http://www.shot.demon.co.uk
3. th ed. Oxford: Black well science; 2001. p. 307-18.
4. rd ed. UK: Leeds blood center; 2003. P. 41-66.
5. th ed. UK: Butterworth Heinemann; 1999.p. 215-34.
6. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1.499-507.
7. Rao MP, Boralessa H, Morgan C, Soni N, Goldhill DR, Brett SJ, Boralessa H, Contreras M; North Thames Blood Interest Group. Anaesthesia 2002; 57: 527-9.
8. Chiavetta JÁ, Herst R, Freedman J, Axcell TJ, Wall AJ, van Rooy SC. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996; 36: 699-706.
9. Henderson RA, Pinder L. N Z Med J. Acute transfusion reactions. 1990; 103(900): 509-11.
10. Climent-Peris C, Vélez-Rosario R. Immediate transfusion reactions. P R Health Sci J. 2001; 20(3):229-35.
11. Bhattacharya P, Marwaha N, Dhawan HK, Roy P, Sharma RR. Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort. Asian J Transfus Sci. 2011; 5(2):164-70.
12. Arewa OP, Akinola NO, Salawu L. Blood transfusion reactions; evaluation of 462 transfusions at a tertiary hospital in Nigeria. Afr J Med Med Sci. 2009; 38(2):143-8.
13. Gauvin F, Lacroix J, Robillard P, Lapointe H, Hume H. Acute transfusion reactions in the pediatric intensive care unit. Transfusion. 2006; 46(11):1899-908.
14. Lozach P, Vicariot M, Le Niger C, Pomey MP, Lejeune B, Férec C, Chaperon J, Salmi LR. Evaluation of the immediate transfusion reaction incident reporting system at the Brest University Hospital CenterTransfus Clin Biol. 2001; 8(4):343-9.
15. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med. 2003; 127(3):316-20.
16. Grujić J, Gulan Z, Budakov Z. Importance of haemovigilance and reports on transfusion reaction in blood component therapy. Med Pregl. 2012; 65(1-2):50-3.
17. Jonathan P. Wallis, Anatole Lubenko, Angus W. Wells, Catherine E. Chapman. Single hospital experience of TRALI. Transfusion 2003; 43:1053-9.
18. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 15; 101(2):454-62.
19. Sunita Saxena, Ira A Shulman. Resurgence of the blood utilization committee. Transfusion 2003; 43: 998-1006.
20. Ahmadi D. Frequency of minor blood group alloantibodies in beta-Thalassemia major blood recipients in Kermanshah (1999). Behbood 2000; 5(1): 50-55.
21. Lavoie J. Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth. 201; 21(1):14-24.
22. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev. 2003; 17(2):120-62.
23. Sarkodee-Adoo CB, Kendall JM, Sridhara R, Lee EJ, Schiffer CA. The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion. 1998; 38(3):229-35.
24. Kelley DL, Mangini J, Lopez-Plaza I, Triulzi DJ. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions. Transfusion. 2000; 40(4):439-42.
25. Menitove JE, McElligott MC, Aster RH. Febrile transfusion reaction: what blood component should be given next? Vox Sang. 1982; 42(6):318-21.
26. Widmann FK. Untoward effects of blood transfusion: common problems and simple safeguards. Postgrad Med. 1981; 69(2):40-4.
27. Dzieczkowski JS, Barrett BB, Nester D, Campbell M, Cook J, Sugrue M, Andersen JW, Anderson KC. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion. 1995; 35(1):20-5.
28. Sokolovic M, Pastores SM. Transfusion therapy and acute lung injury. Expert Rev Respir Med. 2010; 4(3):387-93.
29. Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev. 2001; 15(2):69-83.